Medical marijuana advocates want drug reclassified

October 16, 2012 by Frederic J. Frommer

(AP)—A federal appeals court in Washington is considering whether marijuana should be reclassified from its current status as a dangerous drug with no accepted medical use.

Last year, the rejected a petition by medical marijuana advocates to change the classification—thus keeping marijuana in the same category as drugs such as heroin. The DEA concluded that there wasn't a consensus of medical opinion on using marijuana for medical purposes.

Advocates want the U.S. for the District of Columbia Circuit to force the agency to hold a hearing and conduct findings based on the scientific record.

A lawyer for the advocates told the judges on Tuesday that the DEA has misapplied the law. A government lawyer urged the court to deny the request.

Explore further: Federal government says marijuana has no accepted medical use

shares

Related Stories

Federal government says marijuana has no accepted medical use

July 13, 2011
Marijuana has been approved by many states and the nation's capital to treat a range of illnesses, but the federal government has ruled that it has no accepted medical use and should remain classified as a dangerous drug ...

US governors seek federal marijuana clearance

December 1, 2011
A pair of US governors have filed a petition asking the US federal government to allow wider use of medical marijuana by authorizing doctors to prescribe it and pharmacies to provide it.

Arkansas court upholds medical marijuana proposal

September 27, 2012
(AP)—The Arkansas Supreme Court upheld a proposed ballot measure Thursday that, if successful, would make the state the first in the more conservative southern U.S. to legalize medical marijuana.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.